DE69214841D1 - Enzymatische analyse unter verwendung eines substrates, dass einen fluoreszierenden nierderschlag ergibt - Google Patents

Enzymatische analyse unter verwendung eines substrates, dass einen fluoreszierenden nierderschlag ergibt

Info

Publication number
DE69214841D1
DE69214841D1 DE69214841T DE69214841T DE69214841D1 DE 69214841 D1 DE69214841 D1 DE 69214841D1 DE 69214841 T DE69214841 T DE 69214841T DE 69214841 T DE69214841 T DE 69214841T DE 69214841 D1 DE69214841 D1 DE 69214841D1
Authority
DE
Germany
Prior art keywords
aromatic ring
aromatic
carbons
joined
membered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69214841T
Other languages
English (en)
Other versions
DE69214841T2 (de
Inventor
Richard Haugland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Molecular Probes Inc
Original Assignee
Molecular Probes Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Probes Inc filed Critical Molecular Probes Inc
Publication of DE69214841D1 publication Critical patent/DE69214841D1/de
Application granted granted Critical
Publication of DE69214841T2 publication Critical patent/DE69214841T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D263/57—Aryl or substituted aryl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C07D277/66—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2 with aromatic rings or ring systems directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509—Six-membered rings
    • C07F9/6512—Six-membered rings having the nitrogen atoms in positions 1 and 3
    • C07F9/65128—Six-membered rings having the nitrogen atoms in positions 1 and 3 condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539—Five-membered rings
    • C07F9/6541—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/42—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving phosphatase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2334/00—O-linked chromogens for determinations of hydrolase enzymes, e.g. glycosidases, phosphatases, esterases

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Peptides Or Proteins (AREA)
  • Quinoline Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69214841T 1991-08-23 1992-08-21 Enzymatische analyse unter verwendung eines substrates, dass einen fluoreszierenden nierderschlag ergibt Expired - Lifetime DE69214841T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/748,860 US5316906A (en) 1991-08-23 1991-08-23 Enzymatic analysis using substrates that yield fluorescent precipitates
PCT/US1992/006957 WO1993004077A1 (en) 1991-08-23 1992-08-21 Enzymatic analysis using substrates that yield fluorescent precipitates

Publications (2)

Publication Number Publication Date
DE69214841D1 true DE69214841D1 (de) 1996-11-28
DE69214841T2 DE69214841T2 (de) 1997-05-28

Family

ID=25011237

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69214841T Expired - Lifetime DE69214841T2 (de) 1991-08-23 1992-08-21 Enzymatische analyse unter verwendung eines substrates, dass einen fluoreszierenden nierderschlag ergibt

Country Status (7)

Country Link
US (2) US5316906A (de)
EP (1) EP0641351B1 (de)
JP (1) JP3130316B2 (de)
AT (1) ATE144524T1 (de)
CA (1) CA2115461C (de)
DE (1) DE69214841T2 (de)
WO (1) WO1993004077A1 (de)

Families Citing this family (126)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723218A (en) * 1990-04-16 1998-03-03 Molecular Probes, Inc. Dipyrrometheneboron difluoride labeled flourescent microparticles
GB9126260D0 (en) * 1991-12-11 1992-02-12 Pfizer Ltd Therapeutic agents
US5459268A (en) * 1993-10-25 1995-10-17 Molecular Probes, Inc. Xanthylium dyes that are well retained in mitochondria
ATE280243T1 (de) * 1994-04-29 2004-11-15 Johnson & Johnson Clin Diag Homogenes verfahren zum nachweis von doppelstrang-nukleinsäuren mittels fluoreszierender farbstoffe und dafür nützliche kits
US5589328A (en) * 1994-08-04 1996-12-31 Mahant; Vijay K. Chemiluminescence assays based on indoxyl substrates, thioindoxyl substrates and other substrates
US5718915A (en) * 1994-10-31 1998-02-17 Burstein Laboratories, Inc. Antiviral liposome having coupled target-binding moiety and hydrolytic enzyme
US5750340A (en) * 1995-04-07 1998-05-12 University Of New Mexico In situ hybridization solution and process
US6022689A (en) * 1995-04-07 2000-02-08 University Of New Mexico Situ hybridization slide processes
US5698411A (en) * 1995-05-18 1997-12-16 Coulter Corporation Method for determining activity of enzymes in metabolically active whole cells
US5733719A (en) * 1995-05-18 1998-03-31 Coulter Corporation Method of making an assay compound
US5776720A (en) * 1995-05-18 1998-07-07 Coulter Corporation Assay reagent
US5871946A (en) * 1995-05-18 1999-02-16 Coulter Corporation Method for determining activity of enzymes in metabolically active whole cells
US5869689A (en) * 1995-10-17 1999-02-09 Molecular Probes, Inc Stains for acidic organelles
US6004536A (en) * 1995-11-14 1999-12-21 Molecular Probes, Inc. Lipophilic cyanine dyes with enchanced aqueous solubilty
US5854033A (en) 1995-11-21 1998-12-29 Yale University Rolling circle replication reporter systems
US5968831A (en) * 1996-10-29 1999-10-19 Coulter International Corp. Cell control used to confirm enzymatic activity
DE19651886A1 (de) * 1996-12-13 1998-06-18 Merck Patent Gmbh Mittel und Verfahren zur Bestimmung von hydrolytischen Enzymen
US6207365B1 (en) 1996-12-16 2001-03-27 Laboratory Of Molecular Biophotonics Fluorescent enzyme substrates and method for determining enzyme activities
US5877310A (en) * 1997-04-25 1999-03-02 Carnegie Mellon University Glycoconjugated fluorescent labeling reagents
US6194146B1 (en) 1997-06-13 2001-02-27 Bioseparations, Inc. Situ and in vitro hybridization method and buffer
US5948617A (en) * 1997-06-13 1999-09-07 Biospeparations, Inc. Methods of in situ hybridization
US6140051A (en) * 1997-07-21 2000-10-31 Promega Biosciences, Inc. Fluorescent dibenzazole derivatives and methods related thereto
US5972639A (en) * 1997-07-24 1999-10-26 Irori Fluorescence-based assays for measuring cell proliferation
US6342611B1 (en) * 1997-10-10 2002-01-29 Cytovia, Inc. Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for capsases and other enzymes and the use thereof
DE59803108D1 (de) * 1997-11-12 2002-03-21 Bayer Ag 2-phenyl-substituierte imidazotriazinone als phosphodiesterase inhibitoren
US6218114B1 (en) * 1998-03-27 2001-04-17 Academia Sinica Methods for detecting differentially expressed genes
WO2000004007A1 (en) * 1998-07-17 2000-01-27 Promega Biosciences, Inc. Fluorescent dibenzazole derivatives and methods related thereto
WO2000004914A1 (en) 1998-07-21 2000-02-03 Cytovia, Inc. Novel fluorescence dyes and their applications for whole cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof
DE69934572T2 (de) 1998-10-27 2007-04-26 Molecular Probes, Inc., Eugene Übergangsmetallkomplex-haltige lumineszente proteinfarben
WO2000028326A1 (fr) * 1998-11-06 2000-05-18 Iatron Laboratories, Inc. Nouveaux complexes contenant de l'avidine reticulee, procede analytique dans lequel on utilise de l'avidine reticulee, reactifs et kits d'analyse
US6348324B1 (en) 1999-01-21 2002-02-19 Hypoguard America Limited Composition and device for detecting leukocytes in urine
US6528652B1 (en) 1999-01-21 2003-03-04 Chronimed Composition and device for detecting leukocytes in urine
EP1179087B1 (de) 1999-05-17 2019-03-27 Caliper Life Sciences, Inc. Fokusierung von mikropartikeln in mikrofluidischen systemen
US6329205B1 (en) 1999-08-31 2001-12-11 Molecular Probes, Inc. Detection method using luminescent europium-based protein stains
US6770468B1 (en) 1999-09-14 2004-08-03 Genzyme Glycobiology Research Institute, Inc. Phosphodiester-α-GlcNAcase of the lysosomal targeting pathway
US6642038B1 (en) 1999-09-14 2003-11-04 Genzyme Glycobiology Research Institute, Inc. GlcNAc phosphotransferase of the lysosomal targeting pathway
US7230000B1 (en) 1999-10-27 2007-06-12 Cytokinetics, Incorporated Methods and compositions utilizing quinazolinones
US6545004B1 (en) 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
US7514067B2 (en) 2000-04-25 2009-04-07 President And Fellows Of Harvard College Methods for tumor diagnosis and therapy
US6531283B1 (en) * 2000-06-20 2003-03-11 Molecular Staging, Inc. Protein expression profiling
AU2001278135A1 (en) 2000-08-03 2002-02-18 Cytovia, Inc. Method of identifying immunosuppressive agents
AU8475301A (en) * 2000-08-07 2002-02-18 Univ Vanderbilt Detection of cox-2 activity and anandamide metabolites
US6967251B2 (en) * 2000-10-02 2005-11-22 Molecular Probes, Inc. Reagents for labeling biomolecules having aldehyde or ketone moieties
BR0209541A (pt) * 2001-05-09 2004-04-20 Bayer Healthcare Ag Uso das imidazotriazinonas 2-fenil-substituìdas
US20030027229A1 (en) * 2001-06-01 2003-02-06 Cytovia, Inc. Methods of identifying potentially therapeutically selective and effective anti-cancer agents that are inducers of apoptosis
US7439319B2 (en) * 2001-09-14 2008-10-21 Burnham Institute For Medical Research Selective substrates for matrix metalloproteinases
US20050069962A1 (en) * 2001-10-12 2005-03-31 Archer Robert M Antibody complexes and methods for immunolabeling
US8323903B2 (en) 2001-10-12 2012-12-04 Life Technologies Corporation Antibody complexes and methods for immunolabeling
US6942972B2 (en) 2001-10-24 2005-09-13 Beckman Coulter, Inc. Efficient synthesis of protein-oligonucleotide conjugates
US6753428B2 (en) * 2001-11-20 2004-06-22 Cytokinetics, Inc. Process for the racemization of chiral quinazolinones
US6972326B2 (en) 2001-12-03 2005-12-06 Molecular Probes, Inc. Labeling of immobilized proteins using dipyrrometheneboron difluoride dyes
US6800472B2 (en) * 2001-12-21 2004-10-05 Genzyme Glycobiology Research Institute, Inc. Expression of lysosomal hydrolase in cells expressing pro-N-acetylglucosamine-1-phosphodiester α-N-acetyl glucosimanidase
US20030124652A1 (en) * 2001-12-21 2003-07-03 Novazyme Pharmaceuticals, Inc. Methods of producing high mannose glycoproteins in complex carbohydrate deficient cells
US6905856B2 (en) 2001-12-21 2005-06-14 Genzyme Glycobiology Research Institute, Inc. Soluble GlcNAc phosphotransferase
US7553619B2 (en) 2002-02-08 2009-06-30 Qiagen Gmbh Detection method using dissociated rolling circle amplification
US7009049B2 (en) * 2002-02-15 2006-03-07 Cytokinetics, Inc. Syntheses of quinazolinones
CA2483868A1 (en) * 2002-05-03 2004-05-21 Molecular Probes, Inc. Compositions and methods for detection and isolation of phosphorylated molecules
US20040171034A1 (en) * 2002-05-03 2004-09-02 Brian Agnew Compositions and methods for detection and isolation of phosphorylated molecules
US7445894B2 (en) * 2002-05-03 2008-11-04 Molecular Probes, Inc. Compositions and methods for detection and isolation of phosphorylated molecules
WO2003097053A1 (en) 2002-05-09 2003-11-27 Cytokinetics, Inc. Compounds, compositions, and methods
JP2006508030A (ja) * 2002-05-09 2006-03-09 サイトキネティクス・インコーポレーテッド ピリミジノン化合物、組成物および方法
WO2003103575A2 (en) * 2002-05-23 2003-12-18 Cytokinetics, Inc. Compounds, compositions, and methods
US7041676B2 (en) * 2002-06-14 2006-05-09 Cytokinetics, Inc. Compounds, compositions, and methods
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
EP1537089A4 (de) * 2002-07-23 2008-04-16 Cytokinetics Inc Verbindungen, zusammenstellungen und verfahren
JP2005536553A (ja) * 2002-08-21 2005-12-02 サイトキネティクス・インコーポレーテッド 化合物、組成物および方法
US7557115B2 (en) * 2002-09-30 2009-07-07 Cytokinetics, Inc. Compounds, compositions, and methods
US20040121338A1 (en) * 2002-12-19 2004-06-24 Alsmadi Osama A. Real-time detection of rolling circle amplification products
US9487823B2 (en) 2002-12-20 2016-11-08 Qiagen Gmbh Nucleic acid amplification
AU2003303460A1 (en) 2002-12-27 2004-07-22 Tibotec Bvba Fluorogenic enzyme substrates and methods of preparation
US8043834B2 (en) 2003-03-31 2011-10-25 Qiagen Gmbh Universal reagents for rolling circle amplification and methods of use
US8445702B2 (en) * 2003-05-05 2013-05-21 Life Technologies Corporation Zinc binding compounds and their method of use
US20050250214A1 (en) * 2004-05-05 2005-11-10 Gee Kyle R Zinc binding compounds and their method of use
US20040248103A1 (en) * 2003-06-04 2004-12-09 Feaver William John Proximity-mediated rolling circle amplification
EP1682534A2 (de) * 2003-11-03 2006-07-26 Cytokinetics, Inc. Pyrimidin-4-onverbindungen, zusammensetzungen und verfahren
US20050148593A1 (en) * 2003-11-07 2005-07-07 Gustave Bergnes Compounds, compositions, and methods
US7776529B2 (en) 2003-12-05 2010-08-17 Life Technologies Corporation Methine-substituted cyanine dye compounds
EP1692112A4 (de) * 2003-12-08 2008-09-24 Cytokinetics Inc Verbindungen, zusammensetzungen und verfahren
US7611863B2 (en) * 2004-01-08 2009-11-03 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. Selective staining of biomembranes using voltage-sensitive dyes
ES2246134B1 (es) * 2004-04-02 2006-12-16 Universidad De Castilla-La Mancha. Sensor molecular fluorescente aplicable a la determinacion cuantitativa de la actividad del enzima fosfatasa alcalina.
DE102004023069A1 (de) * 2004-05-11 2005-12-08 Bayer Healthcare Ag Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil
EP1799844B1 (de) * 2004-09-10 2009-12-23 Genencor International, Inc. Verfahren zur erkennung von zielen
DE102005001989A1 (de) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenöse Formulierungen von PDE-Inhibitoren
DE102005009240A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
EP1863908B1 (de) 2005-04-01 2010-11-17 Qiagen GmbH Reverse transkription und amplifikation von rna bei simultaner degradierung von dna
EP1885718B1 (de) 2005-05-11 2017-03-15 Life Technologies Corporation Chemische fluoreszente verbindungen mit hoher selektivität für doppelstrang-dna sowie verfahren zu ihrer verwendung
US20070037174A1 (en) * 2005-08-12 2007-02-15 Rampal Jang B Chemiluminescent generated fluorescent labeling
EP1762627A1 (de) 2005-09-09 2007-03-14 Qiagen GmbH Verfahren zur Aktivierung einer Nukleinsäure für eine Polymerase-Reaktion
KR20080056250A (ko) * 2005-09-29 2008-06-20 바이엘 헬스케어 아게 비뇨기 장애의 치료를 위한 ｐｄｅ 억제제 및 이들의 조합
ES2434491T3 (es) * 2005-10-13 2013-12-16 Funda��O D. Anna Sommer Champalimaud E Dr. Carlos Montez Champalimaud An�lisis inmunohistoqu�mico multiplex in situ
JP2009524832A (ja) 2006-01-24 2009-07-02 ライフ テクノロジーズ コーポレーション 検体を定量するためのデバイスおよび方法
DK3438131T3 (da) 2006-02-10 2022-04-11 Life Technologies Corp Oligosaccharidmodifikation og mærkning af proteiner
US8114636B2 (en) 2006-02-10 2012-02-14 Life Technologies Corporation Labeling and detection of nucleic acids
JP5295787B2 (ja) * 2006-02-28 2013-09-18 モンタナ ステート ユニバーシティ 核酸に基づく分子的技法を用いて無傷細胞と膜損傷細胞とを識別するためのフェナントリジウム誘導体の使用
DK2029799T3 (da) 2006-04-20 2012-12-10 Becton Dickinson Co Termostabile proteiner og fremgangsmåder til fremstilling og anvendelse heraf
US7959186B2 (en) * 2006-06-30 2011-06-14 Pitney Bowes Inc. Signaling labels and fluorescent ink compositions
WO2008069976A2 (en) * 2006-12-01 2008-06-12 President And Fellows Of Harvard College Compounds and methods for enzyme-mediated tumor imaging and therapy
US8586743B2 (en) 2007-01-30 2013-11-19 Life Technologies Corporation Labeling reagents and methods of their use
FR2916762B1 (fr) * 2007-05-31 2013-11-15 Biomerieux Sa Nouveaux substrats enzymatiques de nitroreductase
FR2916763B1 (fr) * 2007-05-31 2013-11-15 Biomerieux Sa Nouveaux substrats de peptidase
US20100184769A1 (en) * 2007-06-13 2010-07-22 Bayer Schering Pharma Aktiengesellschaft Pde inhibitors for the treatment of hearing impairment
US20100291591A1 (en) * 2007-11-05 2010-11-18 Life Technologies Corporation Novel plating media
US20110124965A1 (en) * 2008-05-08 2011-05-26 Park Jason Y Chemiluminescence enhanced detection
FR2937338B1 (fr) 2008-10-17 2013-03-22 Biomerieux Sa Milieu reactionnel pour la detection et/ou l'identification de bacteries du genre legionella
EP2256103A1 (de) 2009-05-07 2010-12-01 Biosynth AG Neue Anzeigerplattform
EP2266963A1 (de) * 2009-06-19 2010-12-29 Ecole Normale Superieure De Lyon Fluorgenes Peptidasesubstrat
JP3156354U (ja) * 2009-10-14 2009-12-24 株式会社佐藤計量器製作所 手洗い用タイマー装置
US8697714B2 (en) 2010-07-28 2014-04-15 Nanyang Technological University Quinazolinone based fluorogenic probes
WO2012022734A2 (en) 2010-08-16 2012-02-23 Medimmune Limited Anti-icam-1 antibodies and methods of use
US9322046B2 (en) 2010-11-01 2016-04-26 3M Innovative Properties Company Biological sterilization indicator
EP2635699B1 (de) 2010-11-01 2018-03-21 3M Innovative Properties Company Biologischer sterilisationsindikator und anwendungsverfahren dafür
EP2479221A1 (de) * 2010-11-04 2012-07-25 Biosynth AG Neuartige Anwendungen von Indoloindol und Indolochinolinfarbstoffen
EP3269822B1 (de) 2010-11-24 2019-11-27 3M Innovative Properties Company Verfahren zum nachweis einer biologischen aktivität
CN103502218B (zh) 2011-03-04 2016-08-17 生命科技公司 用于缀合生物分子的化合物和方法
WO2013045854A1 (fr) * 2011-09-29 2013-04-04 Ecole Normale Superieure De Lyon Substrat de peptidase fluorogene
WO2015050959A1 (en) 2013-10-01 2015-04-09 Yale University Anti-kit antibodies and methods of use thereof
AU2014329609B2 (en) 2013-10-02 2019-09-12 Humabs Biomed Sa Neutralizing anti-influenza A antibodies and uses thereof
GB201319768D0 (en) 2013-11-08 2013-12-25 Glycosynth Ltd Naphthalene derived chromogenic enzyme substrates
US9372194B2 (en) * 2013-12-23 2016-06-21 Ramdas Pai Fluorescent dyes, labeled conjugates and analytical methods
CN104496915B (zh) * 2014-12-19 2017-05-03 华侨大学 一种喹唑啉酮芳香化合物的合成方法
CN106632088B (zh) * 2015-10-30 2019-04-19 华南理工大学 一种基于喹唑啉酮类化合物的聚集诱导发光探针及其制备方法和应用
EP3443126B1 (de) 2016-04-15 2023-11-15 Icahn School of Medicine at Mount Sinai Gewebeprofilierung unter verwendung von multiplexierten immunhistochemischen aufeinanderfolgenden färbungen
EP3309154A1 (de) * 2016-10-13 2018-04-18 Universite De Geneve Neue verbindungen und verwendungen davon zur detektion von zielmolekülen in einer probe
CN108329366A (zh) * 2018-03-07 2018-07-27 南京工业大学 一种用于检测β-半乳糖苷酶的荧光探针化合物及其制备方法
CN112394050A (zh) * 2019-08-19 2021-02-23 中国科学院天津工业生物技术研究所 一种高通量筛选酮类化合物的检测方法及其在酶筛选中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3169129A (en) * 1963-05-10 1965-02-09 American Cyanamid Co 2-ortho-hydroxy-phenyl-4-(3h)-quinazolinones
US3655664A (en) * 1968-12-12 1972-04-11 Du Pont 2-aryl-4(3h)-quinazolinones
US3526627A (en) * 1969-06-05 1970-09-01 American Cyanamid Co Method for preparation of quinazolones
DE3413118A1 (de) * 1984-04-06 1985-10-24 Miles Laboratories, Inc., Elkhart, Ind. Analysenverfahren und mittel zum nachweis esterolytischer und/oder proteolytischer enzyme
US5017475A (en) * 1985-11-25 1991-05-21 Microbiological Associates, Inc. Fluorescent detection method based on enzyme activated conversion of a fluorophore precursor substrate
DE3942356A1 (de) * 1989-12-21 1991-06-27 Boehringer Mannheim Gmbh Verwendung von 1-arylsemicarbaziden zur stabilisierung von enzymsubstraten, entsprechende verfahren und diagnostisches mittel enthaltend einen solchen stabilisator

Also Published As

Publication number Publication date
EP0641351B1 (de) 1996-10-23
CA2115461C (en) 1996-12-03
EP0641351A1 (de) 1995-03-08
ATE144524T1 (de) 1996-11-15
JP3130316B2 (ja) 2001-01-31
JPH08500961A (ja) 1996-02-06
DE69214841T2 (de) 1997-05-28
US5316906A (en) 1994-05-31
WO1993004077A1 (en) 1993-03-04
US5443986A (en) 1995-08-22

Similar Documents

Publication Publication Date Title
DE69214841D1 (de) Enzymatische analyse unter verwendung eines substrates, dass einen fluoreszierenden nierderschlag ergibt
UY32314A (es) Derivados de 4-fenil-piridina
PE20221283A1 (es) Compuestos triciclicos sustituidos
FR18C1006I1 (fr) Derives de quinoline ayant un groupe azolyle et derives de quinazoline
ATE184000T1 (de) 2-oxindolderivate als tyrosinekinaseinhibitoren
KR850001171A (ko) 퀴놀린 화합물의 제조방법
TW359670B (en) Process for producing quinazolin-4-one derivatives
ES2140888T3 (es) Procedimiento para preparar derivados de quinazolina.
ES2097647T3 (es) Compuestos fotocromicos de naftopirano.
CO5210884A1 (es) DERIVADOS DE 5H-TIAZOLO[3,2-a] PIRIMIDINA
PE20030746A1 (es) DERIVADOS DE PIRIDO [2,1-a] ISOQUINOLINA
DE69330351D1 (de) 5-arylindol-derivate und ihre verwendung als serotonin (5-ht1)-agonisten
YU68896A (sh) Jedinjenja hinolina i nihazolina od koristi u terapiji
EA199800170A1 (ru) Производные 2-(4-замещенного)бензиламино-2-метилпропанамида
ATE275545T1 (de) Arylpiperazinderivate von indol als liganden der rezeptoren 5 ht1-like, 5 ht1b und 5 ht1d
MX9602979A (es) Compuestos heterociclicos terapeuticos.
KR960703864A (ko) 신규한 축합 인단 유도체 및 그의 약학적으로 허용가능한 염(novel fused indan derivative and pharmaceutically acceptable salt thereof)
DK1001937T3 (da) Fremgangsmåde til fremstilling af 2-(3-pyrazolyloxymethylen)nitrobenzener
NO863961L (no) Fremgangsmaate for fremstilling av 3-vinyl- og 3-ethynyl-beta-carbolinderivater.
AU7810787A (en) 6-{2-(3-phenoxy-2-hydroxy-propylamino)-propyl-amino}-5- methyl-pyrizine-3-one derivatives useful as antihyper- tensive agents
DK0712395T3 (da) Fremgangsmåde til fremstilling af fluoralkenylthio-heterocykliske derivater
ES2153424T3 (es) Heterociclocromenos fotocromicos.
EA200200727A1 (ru) Новые производные индола
DK0605033T3 (da) Enzymatisk fremgangsmåde til stereoselektiv fremstilling af en heterobicyklisk alkoholenantiomer
Haughland et al. Enzymatic analysis using substrates that yield fluorescent precipitates

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KRAMER - BARSKE - SCHMIDTCHEN, 81245 MUENCHEN

8380 Miscellaneous part iii

Free format text: PFANDRECHT

8380 Miscellaneous part iii

Free format text: PFANDRECHT AUFGEHOBEN